bioRxivGeneticsPreprint
Efficient identification of trait-associated loss-of-function variants in the UK Biobank cohort by exome-sequencing based genotype imputation
Abstract
The large-scale open access whole-exome sequencing (WES) data of the UK Biobank ~200,000 participants is accelerating a new wave of genetic association studies aiming to identify rare and functional loss-of-function (LoF) variants associated with a broad range of complex traits and diseases, however the community is in short of stringent replication of new associations. In this study, we proposed to merge the WES genotypes and the genome-wide genotyping (GWAS) genotypes of 167,000 UKB Caucasian participants into a combined reference panel, and then to impute 241,911 UKB Caucasian participants who had the GWAS genotypes only. We then proposed to use the imputed data to replicate association identified in the discovery WES sample. Using a leave-100-out imputation strategy in the reference panel, we showed that average imputation accuracy measure r2 is modest to high at LoF variants of all minor allele frequency (MAF) intervals including ultra-rare ones: 0.942 at MAF interval [1%, 50%], 0.807 at [0.1%, 1.0%), 0.805 at [0.01%, 0.1%), 0.664 at [0.001%, 0.01%) and 0.410 at (0, 0.001%). As applications, we studied single variant level and gene level associations of LoF variants with estimated heel BMD (eBMD) and 4 lipid traits: high-density-lipoprotein cholesterol (HDL-C), low-density-lipoprotein cholesterol (LDL-C), triglycerides (TG) and total cholesterol (TC). In addition to replicating dozens of previously reported genes such as MEPE for eBMD and PCSK9 for more than one lipid trait, the results also identified 2 novel gene-level associations: PLIN1 (cumulative MAF=0.10%, discovery BETA=0.38, P=1.20x10-13; replication BETA=0.25, P=1.03x10-6) and ANGPTL3 (cumulative MAF=0.10%, discovery BETA=-0.36, P=4.70x10-11; replication BETA=-0.30, P=6.60x10-11) for HDL-C, as well as one novel single variant level association (11:14843853:C:T, MAF=0.11%, discovery BETA=-0.31, P=2.70x10-9; replication BETA=-0.31, P=8.80x10-14, PDE3B) for TG. Our results highlighted the strength of WES based genotype imputation as well as provided useful imputed data within the UKB cohort.
- organism: human
- assay: whole-exome sequencing
- research focus: variant effect prediction
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Whole-exome imputation within UK Biobank powers rare coding variant association and fine-mapping analyses
Alison R. Barton, Maxwell A. Sherman, … Po‐Ru Loh·Nature GeneticsPeer-reviewed·Jul 5, 2021
- Whole exome sequencing and characterization of coding variation in 49,960 individuals in the UK Biobank
Cristopher V. Van Hout, Ioanna Tachmazidou, … Aris Baras·bioRxiv·Mar 9, 2019
- Yield of genetic association signals from genomes, exomes, and imputation in the UK biobank
Sheila M. Gaynor, Tyler Joseph, … Timothy A. Thornton·Nature GeneticsPeer-reviewed·Sep 25, 2024
- Accurate rare variant phasing of whole-genome and whole-exome sequencing data in the UK Biobank
Robin J. Hofmeister, Diogo M. Ribeiro, … Olivier Delaneau·Nature GeneticsPeer-reviewed·Jun 29, 2023
- Rare-variant aggregate association analysis using imputed data is a powerful approach.
Tianyi Liu, Paul Livermore Auer, … Suzanne M. Leal·bioRxiv·Apr 17, 2025
- Surveying the contribution of rare variants to the genetic architecture of human disease through exome sequencing of 177,882 UK Biobank participants
Quanli Wang, Ryan S. Dhindsa, … AstraZeneca Genomics Initiative·bioRxiv·Dec 13, 2020